Selecting corresponding unique next generation sequencing reports
Source:R/select_unique_ngs.R
select_unique_ngs.Rd
For patients with multiple associated next generation (NGS) sequencing reports, select one unique NGS report per patient for the purpose of creating an analytic dataset based on user-defined criterion, including OncoTree code, primary vs. metastatic tumor sample, and earliest vs. most recent sample. If multiple reports for a patient remain available after the user-defined specifications, or if no specifications are provided, the panel with the largest number of genes is selected by default. Sample optimization is performed in the order that the arguments are specified in the function, regardless of the arguments’ order provided by the user. Namely, the OncoTree code is prioritized first, sample type is prioritized second and finally the time is prioritized last. For patients with exactly one genomic sample, that unique genomic sample will be returned regardless of whether it meets the user-specified parameters. Running the select_unique_ngs() function will ensure that the resulting dataset returned by merging the next generation sequencing report data onto the cohort_ca_dx dataset returned by create_analytic_cohort() will maintain the structure of cohort_ca_dx (either one record per patient or one record per diagnosis). Currently, if multiple diagnoses per patient are returned from create_analytic_cohort(), using select_unique_ngs() will select a single NGS report per patient. In future iterations, this will be updated so that one NGS report per diagnosis can be selected.
Usage
select_unique_ngs(
data_cohort,
oncotree_code = NULL,
sample_type = NULL,
min_max_time = NULL
)
Arguments
- data_cohort
CPT (NGS) dataframe returned from the create_analytic_cohort function
- oncotree_code
character vector specifying which sample OncoTree codes to keep. See "cpt_oncotree_code" column of data_cohort argument above to get options.
- sample_type
character specifying which type of genomic sample to prioritize, options are "Primary", "Local" and "Metastasis". Default is to not select a NGS sample based on the sample type.
- min_max_time
character specifying if the first or last genomic sample recorded should be kept. Options are "min" (first) and "max" (last).
Value
returns the 'cohort_ngs' object of the create_analytic_cohort with unique genomic samples taken from each patients.
Details
Note that the NGS dataset serves as the link between the clinical and genomic data, where the NGS dataset includes one record per NGS report per patient, including the NGS sample ID that is used to link to the genomic data files. Merging data from the NGS report onto the analytic cohort returned from create_analytic_cohort() therefore allows users to utilize all clinical and genomic data available.
See the select_unique_ngs vignette for further documentation and examples.
Examples
# Example 1 ----------------------------------
# Create a cohort of all patients with stage IV NSCLC of
# histology adenocarcinoma
set_synapse_credentials()
#> ✔ You are now connected to 'Synapse' with your Personal Access Token (`SYNAPSE_PAT`) for this R session!
#> NULL
nsclc_2_0 <- pull_data_synapse("NSCLC", version = "v2.0-public")
#> ✔ pt_char has been imported for "NSCLC_v2.0"
#> ✔ ca_dx_index has been imported for "NSCLC_v2.0"
#> ✔ ca_dx_non_index has been imported for "NSCLC_v2.0"
#> ✔ ca_drugs has been imported for "NSCLC_v2.0"
#> ✔ prissmm_imaging has been imported for "NSCLC_v2.0"
#> ✔ prissmm_pathology has been imported for "NSCLC_v2.0"
#> ✔ prissmm_md has been imported for "NSCLC_v2.0"
#> ✔ cpt has been imported for "NSCLC_v2.0"
#> ✔ mutations_extended has been imported for "NSCLC_v2.0"
#> ✔ fusions has been imported for "NSCLC_v2.0"
#> ✔ cna has been imported for "NSCLC_v2.0"
ex1 <- create_analytic_cohort(
data_synapse = nsclc_2_0$NSCLC_v2.0,
stage_dx = c("Stage IV"),
histology = "Adenocarcinoma"
)
# select unique next generation sequencing reports for those patients
samples_data1 <- select_unique_ngs(
data_cohort = ex1$cohort_ngs,
sample_type = "Primary"
)
#> ✔ 63 patients with > 1 next generation sequencing reports were identified
#> ✔ 34 of 63 had a unique NGS report selected based on given criteria.
#> ! 29 of 63 did not have a unique NGS report selected based on the selected criteria or by having the largest panel, so a NGS report was selected at random (be sure to set a seed for reproducbility!) See `attributes(<your-results>)$random_samples` to view these sample IDs.
# Example 2 ----------------------------------
# Create a cohort of all NSCLC patients who
# received Cisplatin, Pemetrexed Disodium or Cisplatin,
# Etoposide as their first drug regimen
ex2 <- create_analytic_cohort(
data_synapse = nsclc_2_0$NSCLC_v2.0,
regimen_drugs = c(
"Cisplatin, Pemetrexed Disodium",
"Cisplatin, Etoposide"
),
regimen_order = 1,
regimen_order_type = "within regimen"
)
samples_data2 <- select_unique_ngs(
data_cohort = ex2$cohort_ngs,
oncotree_code = "NSCLCPD",
sample_type = "Metastasis",
min_max_time = "max"
)
#> ✔ 14 patients with > 1 next generation sequencing reports were identified